More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Trump previously met with Ubl and chief executives of U.S. drugmakers Pfizer and Eli Lilly at his Mar-a-Lago estate in Florida in December.

South Carolina Attorney General Alan Wilson announced he is leading 37 states on a territory bipartisan coalition requesting ...

Biosimilars have also made inroads among generic suppliers. But development is lengthy and expensive. McKinsey estimates that ...

In November, Amneal received FDA approval for exenatide, its first generic injectable glucagon-like peptide-1 (GLP-1) agonist ...

The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...

For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...

Natco Pharma stock corrected sharply due to weak Q3 results, but future opportunities like semaglutide offer hope.

Criminals are targeting pharmacies and stealing weight-loss medication in a country with body image insecurities and where ...

Not all weight loss programs are made equal—to reach a healthy, sustainable weight, personalized programs offer the best ...

Spend billions of dollars to cover anti-obesity drugs under Medicare and Medicaid, or deny more than 7 million people access ...